CLINICAL_TRIALS
trial_result
· 2026-03-18
Clinical Trial Update: A Study of Ponsegromab in People With Heart Failure [Phase 2]
Summary
A Phase 2 clinical trial evaluating Ponsegromab in people with heart failure was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2026-03-18